Teladoc Health, Inc. Quarterly Costs and Expenses in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Teladoc Health, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2018 to Q3 2024.
  • Teladoc Health, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $685M, a 5.53% decline year-over-year.
  • Teladoc Health, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $3.6B, a 45.6% decline year-over-year.
  • Teladoc Health, Inc. annual Costs and Expenses for 2023 was $2.85B, a 82.2% decline from 2022.
  • Teladoc Health, Inc. annual Costs and Expenses for 2022 was $16.1B, a 599% increase from 2021.
  • Teladoc Health, Inc. annual Costs and Expenses for 2021 was $2.3B, a 43.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.6B $685M -$40.1M -5.53% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $3.64B $1.48B +$760M +105% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $2.88B $733M +$26.9M +3.81% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $2.85B $696M -$3.76B -84.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $6.61B $725M +$41.8M +6.12% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $6.57B $724M -$2.96B -80.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $9.53B $706M -$6.53B -90.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $16.1B $4.45B +$3.86B +648% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $12.2B $683M +$101M +17.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $12.1B $3.69B +$3.11B +534% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $8.99B $7.23B +$6.7B +1244% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $2.3B $596M -$246M -29.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $2.54B $582M +$274M +88.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $2.27B $582M +$334M +135% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $1.94B $538M +$337M +167% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 $1.6B $842M +$670M +389% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $931M $309M +$151M +95.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $780M $248M +$95.9M +63% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $684M $202M +$50.4M +33.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 $634M $172M +$31.5M +22.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-26
Q3 2019 $602M $158M +$31.2M +24.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $571M $152M +$39.6M +35.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $531M $151M +$42.7M +39.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $489M $141M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $127M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 $113M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 $109M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.